Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals RSUs by Year
RSUs — Weighted-average grant-date fair value of shares granted ($/sh) ($)
Vertex Pharmaceuticals RSUs: $456 in FY2025, up 2.5% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — RSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | RSUs — Weighted-average grant-date fair value of shares granted ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 456 | +2.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 445 | +34.3% | Form 10-K (filed 2025-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 331 | +28.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2022 | Dec 31, 2022 | 258 | +23.9% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 208 | -19.3% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 258 | +42.1% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 182 | +10.4% | Form 10-K (filed 2020-02-13) ↗ |
| FY2018 | Dec 31, 2018 | 165 | +45.6% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 113 | +25.1% | Form 10-K (filed 2018-02-15) ↗ |
| FY2016 | Dec 31, 2016 | 90.46 | -23.5% | Form 10-K (filed 2017-02-23) ↗ |
| FY2015 | Dec 31, 2015 | 118 | – | Form 10-K (filed 2016-02-16) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals RSUs ($), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rsu-granted-wafv
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.